National societies' needs as assessed by the ESTRO National Societies Committee survey: A European perspective
Por:
Garibaldi, C, Jornet, N, Tan, L, Boejen, A, Franco, P, Bussink, J, Troost, EGC, Bak, B, Bibault, JE, Dzhugashvili, M, Van den Berghe, L, Fizaine, L, Leci, A, Ricardi, U, Jereczek-Fossa, BA
Publicada:
1 oct 2020
Resumen:
Purpose: To determine how ESTRO can collaborate with Radiation Oncology National Societies (NS) according to its mission and values, and to define the new roadmap to strengthen the NS network role in the forthcoming years.
Materials and methods: The ESTRO NS committee launched a survey addressed to all European National Societies, available online from June 5th to October 30th 2018. Questions were divided into three main sections: (1) general information about NS; (2) relevant activities (to understand the landscape of each NS context of action); (3) relevant needs (to understand how ESTRO can support the NS). Eighty-nine European NS were invited to participate. Respondents were asked to rank ESTRO milestones in order of importance, indicating the level of priority to their society.
Results: A total of 58 out of 89 NS (65.2%) from 31 European countries completed the questionnaire. The majority of NS ranked "Optimal patient care to cure cancer and to reduce treatment-related toxicity" as the highest level of priority. This aligns well with the ESTRO vision 2030 "Optimal health for all together." NS also indicated a high need for more consensus guidelines and exchange of best practices, access to high quality accredited education, implementation of the ESTRO School Core Curriculum at the national level, and defining quality indicators and standard in Radiation Oncology, improved communication and increased channelling of information.
Conclusion: The results of this survey will be used to strengthen the relations between ESTRO and European NS to promote and develop initiatives to improve cancer care. (C) 2020 Elsevier B.V. All rights reserved.
Filiaciones:
Garibaldi, C:
IRCCS, Unit Radiat Res, IEO European Inst Oncol, Milan, Italy
Jornet, N:
Hosp Santa Creu & Sant Pau, Serv Radiofis & Radioproteccio, Barcelona, Spain
Tan, L:
Cambridge Univ Hosp, Cambridge, England
Boejen, A:
Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
Franco, P:
Univ Turin, Dept Oncol, Turin, Italy
Bussink, J:
Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
Troost, EGC:
Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany
Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
Tech Univ Dresden, Fac Med, Dept Radiotherapy & Radiat Oncol, Dresden, Germany
Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol OncoRay, Dresden, Germany
Bak, B:
Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Radiotherapy 2, Poznan, Poland
Bibault, JE:
Ctr Oscar Lambret, Lille, France
Dzhugashvili, M:
Murcia Univ, Murcia Reg Unity, Genesis Care Spain, Murcia, Spain
Van den Berghe, L:
Univ Hosp, Dept Radiat Oncol, Ghent, Belgium
Fizaine, L:
ESTRO Off, Brussels, Belgium
Leci, A:
ESTRO Off, Brussels, Belgium
Ricardi, U:
Univ Turin, Dept Oncol, Turin, Italy
Jereczek-Fossa, BA:
Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
IRCCS, Div Radiotherapy, IEO European Inst Oncol, Milan, Italy
Bronze, Green Published
|